Article Details

Protalix BioTherapeutics Announces Submission of Type A Meeting Request to the FDA

Retrieved on: 2021-08-02 10:41:15

Tags for this article:

Click the tags to see associated articles and topics

Protalix BioTherapeutics Announces Submission of Type A Meeting Request to the FDA. View article details on HISWAI: https://www.prnewswire.com/il/news-releases/protalix-biotherapeutics-announces-submission-of-type-a-meeting-request-to-the-fda-301345922.html

Excerpt

Protalix is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins expressed through ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up